5-FU-Induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 1965-1971

  Inada, Takao ^a,b   Ichikawa, Akira ^b   Kubota, Tetsuro ^c   Ogata, Yoshiro ^a   Moossa, A R ^e   Hoffman, Robert M ^d,e  

^a Department of Surgery ^*  (Japan)

^b TOCHIGI CANCER CENTER   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d ANTICANCER INC   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

5 fluorouracil; Apoptosis; Gastrointestinal cancer

Indexed keywords

FLUOROURACIL; THYMIDYLATE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER TRANSPLANTATION; CELL CYCLE S PHASE; COLON CANCER; COLON CARCINOMA; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; FLOW CYTOMETRY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOMA; XENOGRAFT;

ANIMALS; APOPTOSIS; COLONIC NEOPLASMS; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; MICE; MICE, NUDE; RNA, NEOPLASM; S PHASE; STOMACH NEOPLASMS; THYMIDYLATE SYNTHASE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030813364     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wyllie AH, Kerr JFR and Curri AR: Cell death: The significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
2. Bursch W, Oberhammer F and Schulte-Hermann R: Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 13: 245-251, 1992.
3. Williams G, Smith T, Spencer E, Dexter TM and Taylor DR: Hematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343: 76-9, 1990.
4. Trauth B, Mas C, Peters A, Matzlcu S, Moller P, Falk W, Debatin K-M and Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305, 1989.
5. Smith C, Williams G, Kingston R, Jenkinson EJ and Owen, JJT: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T-cells in thymic cultures. Nature 337: 181-184, 1989.
6. Kerr JFR, Winterford CM and Harmon, BV: Apoptosis: its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
7. Moertel CG: Chemotherapy for colorectal cancer. N Engl J Med 330: 1136-1143, 1994.
8. Spears CP, Shahinian AM, Moran RG, Heidelberger C and Corbett, TH: In vivo kinetics of thymidylate synthetase inhibition on 5-fluorouracil-sensitive and resistant murine colon adenocarcinomas. Cancer Res 42: 450-456, 1982.
9. Spears CP, Gustavsson BG, Mitchell MS, Spicer D, Berne M, Bernstein L and Danenberg PV: Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res 44: 4144-4150, 1984.
10. Nakamura H, Wang Y, Miyauchi S, Nishioka N, Tanaka H, Harada N, Shirasaka T and Fujii S: Studies on the mechanism of antitumor activity of 5-FU and its derivatives-relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo. Jpn J Cancer Chemother 11: 1049-1055, 1984 (in Japanese).
11. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV and Leichman L: Thymidylate synthetase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1412, 1995.
12. Matsuoka H, Ueo H, Sugimachi K and Akiyoshi T: Preliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response. Cancer Invest 10: 265-269, 1992.
13. Uchida J, Umeno Y and Takada S: Significance of measuring 5-fluorouracil incorporated into RNA of tumor tissue as a parameter for the antitumor activity of 5-fluorouracil and its analogs. Jpn J Cancer Chemother 19: 677-683, 1992 (in Japanese).
14. Kubota T, Nakada M, Tsuyuki K, Inada T, Asanuma F, Ishibiki IC and Abe O: Cell kinetics and chemosensitivity of human carcinomas serially transplanted into nude mice. Jpn J Cancer Res 77: 502-507, 1986.
15. Inada T, Ogata Y, Kubota T, Ozawa I, Hishinuma S, Shimizu H, Kotake K, Ikeda T and Koyama Y: A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer. Surgery Today (Jpn J Surg) 23: 687-692, 1993.
16. Geran RI, Greenberg NH, Schumacher AM and Abott BJ: Protocols for screening chemical agents and natural products against animal tumors and other biological systems 3rd ed.,. Cancer Chemother Rep 3: 51-61, 1972.
17. Isobe Y, Kubota T, Asanuma F, Kurihara H, Inada T, Fukutomi T, Ishibiki K and Abe O: Pharmacodynamic aspects of in vitro and in vivo chemosensitivity tests. Jpn J Cancer Res 78: 983-990, 1987.
18. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
19. Barry MA, Behnke CA, Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990.
20. Kaufmann SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870-5878, 1989.
21. 10-propargyl-5,8-dideazafolic acid. Cancer Res 48: 2036-2041, 1988.
22. Evans RM, Laskin JD and Hakala MT: Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and human cells. Cancer Res 40: 4113-4122, 1980.
23. Yoshioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, Garett C and Wataya Y: Deoxyribonucleoside-triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J Biol Chem 262: 8235-8241, 1987.